Hyperlipidaemia and renal disease (Q37786745)

23 August 2017

1 reference

title

Hyperlipidaemia and renal disease (English)

1 reference

23 August 2017

1 reference

Short CD

1

1 reference

23 August 2017

Durrington PN

series ordinal

2

1 reference

23 August 2017

publication date

1 December 1990

1 reference

Bailliere's clinical endocrinology and metabolism

23 August 2017

published in

1 reference

23 August 2017

volume

4

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

777-806

1 reference

Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: lipid alterations and glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Serum apolipoprotein profile of patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hypertriglyceridemia. A metabolic consequence of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Is there a role for polyunsaturated fatty acids in the prevention of renal disease and renal failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Serum lipid and lipoprotein alterations in nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Normal serum-lipids in renal-transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Ischaemic heart-disease as a complication of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Borderline hypercholesterolaemia: when to introduce drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lecithin: cholesterol acyltransferase activity in dialyzed and undialyzed chronic uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Prevalence of serum lipid abnormalities in chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipid abnormalities in uremia, dialysis, and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Plasma lecithin-cholesterol acyltransferase activities in uraemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Plasma LCAT activities in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hyperlipoproteinaemias in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

The mechanism of hyperlipidaemia in nephrotic syndrome--role of low albumin and the LCAT reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Heparin-Released Plasma Lipases in Chronic Renal Failure and after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lp(a) lipoprotein/pre-ß1-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Secondary hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipoprotein lipid abnormalities in healthy renal transplant recipients: persistence of low HDL2 cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Effect of chronic renal failure on high-density lipoprotein kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

The immunochemical determination of apolipoprotein A, total apolipoprotein A-I and 'free' apolipoprotein A-I in serum of patients on chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

1 reference

7 January 2021

Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Treatment of nephrotic hyperlipoproteinemia with gemfibrozil

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Management of hyperlipidemia of kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipoproteins and apolipoproteins during the progression of chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipid Metabolism in Uremia: Effect of Regular Hemofiltration and Hemodialysis Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hyperlipoproteinemia in renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Deaths from Occlusive Arterial Disease in Renal Allograft Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Preservation of function in experimental renal disease by dietary restriction of phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Effect of probucol on hyperlipidemia in patients with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Relationship between vascular disease and age-associated changes in the human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Glomerular sclerosis in patients with massive obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Persistent hyperlipidemia in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Renal injury of diet-induced hypercholesterolemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lovastatin treatment of hypercholesterolemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

The role of lipids in progressive glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hyperlipidemia and the progression of renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Plasma Triglyceride Metabolism in the Adult Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Effects of dietary fish oil on serum lipids and blood coagulation in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Accelerated atherosclerosis in prolonged maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Plasma lipoproteins and lecithin:cholesterol acyltransferase distribution in patients on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

The Nephrotic Syndrome and Ischaemic Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hepatic Secretion of Lipoproteins in the Rat and the Effect of Experimental Nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

High density lipoproteinuria in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

A potential basis for the thrombotic risks associated with lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Selective Deficiency of Hepatic Triglyceride Lipase in Uremic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipoprotein distribution and composition in the human nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Serum apolipoproteins A and B, lecithin: cholesterol acyl transferase activities and urinary cholesterol levels in nephrotic syndrome patients before and during steroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

The effect of renal failure and haemodialysis on the concentration of free apolipoprotein A-1 in serum and the implications for the catabolism of high-density lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Increased lipoprotein-remnant formation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipolytic enzymes and plasma lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Increased frequency of late pre- beta lipoproteins (LP beta) in isolated serum very low density lipoproteins in uraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipid Disorders in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipoprotein profiles at different stages of the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

An inquiry into the mechanism of hypertriglyceridemia in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Changes in lipoproteins induced by the remnant kidney tissue or binephrectomy in chronic uremic patients treated by hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Prospective randomised trial of early dietary protein restriction in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Reduction of plasma triglycerides by diet in subjects with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Response of plasma triglycerides to dietary change in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

High-density lipoprotein in chronic renal failure and after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Serum and urinary lipoproteins in the human nephrotic syndrome: evidence for renal catabolism of lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Serum and urinary high density lipoproteins in glomerular disease with proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

High-density lipoprotein cholesterol in patients with untreated and treated nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Factors in the differential rate of arteriosclerosis (AS) between long surviving renal transplant recipients and dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

STUDIES ON THE METABOLISM OF THE SERUM PROTEINS AND LIPIDS IN A PATIENT WITH ANALBUMINEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Low-density lipoprotein metabolism in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Cardiovascular Disease and the Nephrotic Syndrome: the other Side of the Coin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Does the nephrotic syndrome increase the risk of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Cardiovascular-related causes of death and the fate of patients with renovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Lipoprotein lipase in clinical and experimental nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

Further definition of lipid-lipoprotein abnormalities in children with various degrees of chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980079-5

7 January 2021

10.1016/S0950-351X(05)80079-5

Identifiers

DOI

1 reference

23 August 2017

1 reference